MELASMA
OVERVIEW
Melasma is a chronic, recurrent pigmentary condition characterized by symmetrical brown or gray-brown patches that most commonly affect the face, including the cheeks, forehead, upper lip, and chin. It occurs more frequently in women and individuals with darker skin types.
Melasma is benign and not contagious, but it can be persistent and cosmetically distressing. Pigmentation can often be significantly improved with appropriate medical management, consistent photoprotection, and long-term maintenance, although recurrence is common.
COMMON FEATURES OF MELASMA
Melasma may present with:
- Brown, tan, or gray-brown patches with irregular borders
- Symmetrical facial pigmentation
- Gradual darkening following sun exposure
- Worsening during pregnancy or other hormonal changes
- Recurrence after periods of improvement
Unlike freckles or isolated sun spots, melasma is a chronic pigmentary condition with a tendency to recur.
WHAT CAUSES MELASMA?
Melasma results from increased pigment production and complex interactions between melanocytes, ultraviolet and visible light exposure, hormonal influences, and individual predisposition.
Important contributing factors include:
- Ultraviolet (UV) and visible light exposure
- Hormonal influences, including pregnancy and hormone therapy
- Genetic predisposition
- Certain medications and photosensitizing agents
- Heat and environmental exposure in some patients
Because multiple factors contribute to melasma and pigmentation may occur at different levels within the skin, treatment response varies and long-term management is often necessary.
MEDICAL MANAGEMENT OF MELASMA
Melasma treatment follows a stepwise, conservative-first approach. Initial management focuses on reducing pigment stimulation, controlling active pigmentation, and preventing further darkening.
Medical management may include:
- Consistent daily photoprotection
- Prescription topical therapy to reduce excess pigmentation
- Gentle skin care to protect the skin barrier and minimize inflammation
- Identification and modification of contributing hormonal, medication-related, or environmental factors
Laser treatment is not first-line therapy for melasma.
Successful management depends not only on treatment of existing pigmentation but also on controlling factors that continue to stimulate pigment production. Ongoing ultraviolet and visible-light exposure can significantly limit improvement and contribute to recurrence.
ROLE OF PROCEDURAL AND LASER TREATMENTS IN MELASMA
Procedural treatments may be considered selectively for persistent residual pigmentation after appropriate medical management and stabilization of melasma. These treatments are adjunctive rather than curative and do not replace medical management or consistent photoprotection.
In selected patients, low-fluence pigment-targeting laser treatment or non-ablative fractional laser treatment may be incorporated into the treatment plan. Treatment selection and parameters depend on skin type, pigmentation pattern, previous treatment response, and clinical presentation. Because excessive inflammation or overly aggressive treatment can worsen melasma or trigger post-inflammatory hyperpigmentation, particularly in darker skin types, laser treatment is approached conservatively.
LONG-TERM MANAGEMENT
Melasma commonly follows a course of improvement and recurrence. Pigmentation often improves gradually, and continued maintenance is important even after visible discoloration has diminished.
Long-term control centers on photoprotection, prevention of unnecessary skin inflammation, appropriate medical therapy, and selective procedural treatment.
Discuss Melasma Evaluation and Management
Persistent or recurrent facial pigmentation can be evaluated to confirm the diagnosis of melasma, distinguish it from other causes of facial pigmentation, and establish an appropriate management plan.
📞 Call (847) 518-9999 to schedule a dermatology evaluation.
Medical Disclaimer
This information is provided for educational purposes only and does not
replace individualized medical evaluation. Treatment recommendations depend
on clinical findings, diagnostic requirements, and patient-specific factors.
Outcomes may vary, and no specific medical result can be guaranteed.
Learn More About
